Search

Your search keyword '"Varroud-Vial, Nicolas"' showing total 7 results
Start Over Author "Varroud-Vial, Nicolas" Search Limiters Full Text
7 results on '"Varroud-Vial, Nicolas"'

1. Auteurs

Author

Furber Alain, Laissy Jean-Pierre, Alison Daniel, Aubry Pierre, Azarine Arshid, Barone-Rochette Gilles, Barral Pierre-Antoine, Bartoli Axel, Ben Driss Ahmed, Bière Loïc, Boccalini Sara, Boschat Jacques, Boussel Louis, Brochet Éric, Cadour Farah, Cammilleri Serge, Cassagnes Lucie, Caussin Christophe, Charpentier Étienne, Chergui Naima, Christiaens Luc-Philippe, Clerfond Guillaume, Cochet Hubert, Cohen-Solal Alain, Crochet Dominique, Croisille Pierre, Dacher Jean-Nicolas, Deux Jean-François, Didier Romain, Diebold Benoit, Dorczynski Chloé, Douek Philippe, Extramania Fabrice, Ferrières Jean, Garcia Gabriel, Garot Jérôme, Genée Olivier, Ghekiere Olivier, Ghelis Nil, Gilard Martine, Guérin Patrice, Habib Gilbert, Hamon Michèle, Hebert Thomas, Hyafil Fabien, Jacquier Alexis, Kastler Bruno, Lairez Olivier, Larralde Antoine, Le Ven Florent, Macron Laurent, Mandry Damien, Mewton Nathan, Mousseaux Élie, Nicol Martin, Ohana Mickaël, Ou Phalla, Parsaï Chirine, Petermann Antoine, Pezel Théo, Pontana François, Pucheux Julien, Rapacchi Stanislas, Redheuil Alban, Revel Mouroz Paul, Ribeyrolles Sophie, Rousseau Hervé, Serfaty Jean-Michel, Si-Mohamed Salim, Sirol Marc, Soulat Gilles, Sridi-Cheniti Soumaya, Varroud-Vial Nicolas, Vermes Emmanuelle, Vernhet-Kovacsik Hélène, Warin-Fresse Karine, and Willoteaux Serge

Published
2021

4. Left ventricular outflow tract obstruction secondary to accessory mitral valve tissue: a multimodality imaging approach

Author

Vergé Marie-Philippe, Varroud-Vial Nicolas, Christiaens Luc-Philippe, and Jayle Christophe

Subjects
Male, medicine.medical_specialty, Ventricular outflow tract obstruction, Obstructive cardiomyopathy, Multimodal Imaging, Alcohol ablation, Ventricular Outflow Obstruction, Coronary artery disease, Internal medicine, Mitral valve, Medicine, Humans, Heart Valve Prosthesis Implantation, business.industry, Exertional dyspnoea, Middle Aged, medicine.disease, humanities, medicine.anatomical_structure, Dyspnea, Echocardiography, Heart Valve Prosthesis, Cardiology, Mitral Valve, medicine.symptom, Cardiology and Cardiovascular Medicine, business, Disopyramide, Tomography, X-Ray Computed, Hospital department, Magnetic Resonance Angiography, medicine.drug
Abstract

A 48-year-old male was referred to our hospital department for septal alcohol ablation of a hypertrophic obstructive cardiomyopathy, known for 4 years. Despite the treatment with β-blockers, then isoptine and disopyramide, he was still symptomatic with a disabling exertional dyspnoea. The cardiac-CT with retrospective acquisition found non-significant coronary artery disease. The septal wall was 12-mm …

Published
2014

6. Pancarditis: an unusual complication of a group B streptococcal infection

Author

Larrieu-Ardilouze, Elisa, Christiaens, Luc, Varroud-Vial, Nicolas, Madico, Coralie, Hajj-Chahine, Jamil, and Rehman, Michaela B.

Abstract

AbstractPancarditis is a rare condition with a poor prognosis combining endocarditis, myocarditis with abscess formation, and purulent pericarditis. Diagnosis is often delayed and the clinical signs are predominantly those of the embolic complications. Literature is scarce. We present a unique and rare case of pancarditis, complicating a Streptococcal B infection in an immunocompetent, healthy, 54 year-old woman. The evolution was favourable under medical therapy alone and thanks to multimodality cardiac imaging diagnosis and follow-up.

Published
2018
Full Text
View/download PDF

7. Prognostic value of left atrial function in systemic light-chain amyloidosis: a cardiac magnetic resonance study.

Author

Mohty D, Boulogne C, Magne J, Varroud-Vial N, Martin S, Ettaif H, Fadel BM, Bridoux F, Aboyans V, Damy T, and Jaccard A

Subjects
Age Factors, Aged, Amyloidosis mortality, Amyloidosis physiopathology, Analysis of Variance, Cardiomyopathies mortality, Cardiomyopathies physiopathology, Cohort Studies, Confidence Intervals, Databases, Factual, Female, France, Heart Atria pathology, Humans, Immunoglobulin Light Chains blood, Immunoglobulin Light-chain Amyloidosis, Kaplan-Meier Estimate, Male, Middle Aged, Predictive Value of Tests, Prognosis, Proportional Hazards Models, Prospective Studies, ROC Curve, Risk Assessment, Severity of Illness Index, Sex Factors, Survival Analysis, Amyloidosis diagnostic imaging, Cardiomyopathies diagnostic imaging, Heart Atria diagnostic imaging, Image Interpretation, Computer-Assisted, Magnetic Resonance Imaging, Cine methods, Stroke Volume physiology
Abstract

Background: Cardiac involvement in systemic light-chain amyloidosis (AL) imparts an adverse impact on outcome. The left atrium (LA), by virtue of its anatomical location and muscular wall, is commonly affected by the amyloid process. Although LA infiltration by amyloid fibrils leads to a reduction in its pump function, the infiltration of the left ventricular (LV) myocardium results in diastolic dysfunction with subsequent increase in filling pressures and LA enlargement. Even though left atrial volume (LAV) is an independent prognostic marker in many cardiomyopathies, its value in amyloid heart disease remains to be determined. In addition, few data are available as to the prognostic value of LA function in systemic AL. Using cardiac magnetic resonance (CMR), the current study aims to assess the prognostic significance of the maximal LAV and total LA emptying fraction (LAEF) in patients with AL., Methods and Results: Fifty-four consecutive patients (age 66 ± 10 years, 59% males) with confirmed systemic AL and mean LV ejection fraction of 60 ± 12% underwent CMR. As compared with patients with no or minimal cardiac involvement (Mayo Clinic [MC] stage I), those at moderate and high risk (MC stages II and III) had significantly larger indexed maximal LAV (36 ± 15 vs. 46 ± 13 vs. 52 ± 19 mL/m(2), P = 0.03) and indexed minimal LAV (20 ± 6 vs. 34 ± 11 vs. 44 ± 17 mL/m(2), P < 0.001), lower LAEF (42 ± 9 vs. 26 ± 13 vs. 16 ± 9%, P < 0.0001) but similar LVEF. Furthermore, myocardial late gadolinium enhancement (LGE) was more frequent and significantly associated with lower LAEF. LAEF was also significantly lower in symptomatic (NHYA ≥ II, 22 ± 14%) as compared with asymptomatic patients (NYHA class I, 33 ± 13%, P = 0.006). Two-year survival rate was lower in patients with LAEF ≤ 16% as compared with those with LAEF > 16% (37 ± 11 vs. 94 ± 4%, P = 0.001). In multivariate analysis, lower LAEF remained independently associated with a higher risk of 2-year mortality (HR = 1.08 per 1% decrease, 95% CI: 1.02-1.15, P = 0.003)., Conclusion: In patients with systemic AL, LAEF as assessed by CMR is associated with NYHA functional class, MC stage, myocardial LGE and 2-year mortality., (Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2016. For permissions please email: journals.permissions@oup.com.)

Published
2016
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results